Q-Factor

Q-Factor is an Israeli deep-tech startup founded in early 2026 and emerged from stealth in April 2026 with $24 million in seed funding. The company is building full-scale quantum computers using neutral atom technology, positioning itself as a leader in the race to achieve practical, large-scale quantum computing. The founding team comprises world-class physicists from Israel's top research institutions: Prof. Nir Davidson and Prof. Ofer Firstenberg from the Weizmann Institute of Science, Prof. Yoav Sagi from the Technion – Israel Institute of Technology, and Dr. Guy Raz, a deep-tech commercialization veteran with two decades of experience scaling quantum and advanced technology ventures.

The technical foundation of Q-Factor rests on neutral-atom quantum computing, a leading quantum platform distinct from superconducting qubits (IBM, Google) and photonic systems. In neutral-atom approaches, individual atoms (typically alkaline earth or alkali atoms) are optically trapped and manipulated, with quantum information encoded in their energy levels. Qubits interact via Rydberg states—highly excited atomic states that create strong, controllable interactions between atoms. This architecture offers critical advantages: inherent scalability (atoms can be arrayed in large grids with no fundamental physical barriers to scaling), naturally long coherence times (high "Q-factor," enabling thousands of sequential quantum operations per qubit before decoherence), and configurability (allowing flexible qubit connectivity and rearrangement). These properties position neutral atoms as uniquely suited for scaling to hundreds of thousands or millions of qubits, a capability essential for solving meaningful problems in cryptanalysis, molecular simulation, optimization, and machine learning.

The market opportunity for quantum computing spans both commercial and national-security applications. On the commercial side, enterprises in pharmaceuticals, materials science, financial services, and artificial intelligence are investing billions in quantum computing capabilities for applications from drug discovery acceleration to portfolio optimization to training advanced AI models. On the defense and national-security side, quantum computing poses both an opportunity and an existential threat: nation-states recognize that cryptographically-relevant quantum computers (CRQCs) could break current encryption standards, creating urgent incentives to develop post-quantum cryptography and to build indigenous quantum capabilities. Intelligence agencies, defense ministries, and critical infrastructure operators are actively developing quantum-resistant security architectures and seeking scalable quantum platforms for advanced applications in sensing, navigation, and communications.

Q-Factor's competitive positioning is formidable. The neutral-atom approach has demonstrable technical advantages over incumbent quantum platforms: compared to superconducting systems (IBM, Google), neutral atoms require no extreme cryogenic cooling, offer better scalability prospects, and have naturally longer coherence times; compared to trapped-ion systems (IonQ, Honeywell), neutral atoms allow parallel operations and easier scaling; compared to photonic systems (Quantum Source, Xanadu), neutral atoms avoid photon loss and detection challenges. Global competitors in neutral-atom quantum computing (QuEra Computing, Pasqal, Atom Computing) have raised comparable or larger funding rounds, but Q-Factor's advantage lies in its founding team's world-leading research credentials, Israeli institutional backing (Technion and Weizmann as shareholders), and direct access to cutting-edge atomic physics research at Technion and Weizmann. The company's roadmap targets "Moore's Law-like" scaling—regular, predictable increases in qubit count and fidelity—a capability that would distinguish Q-Factor from competitors still struggling with error correction and coherence limits.

Q-Factor's strategic relevance is multifaceted. For Israel's technology ecosystem, Q-Factor represents a validation of the country's quantum research leadership and capacity to commercialize deep-science innovation at global scale. The involvement of Technion and Weizmann Institute as institutional shareholders signals commitment to bridging academic breakthroughs and venture-scale deployment. For Western defense and intelligence communities, Q-Factor offers a European/Israeli quantum computing capability outside the U.S. market concentration, creating strategic resilience and allied cooperation pathways. For quantum technology more broadly, Q-Factor's scalability claims (targeting millions of qubits vs current thousands) would represent a generational leap, potentially accelerating timelines to quantum advantage in real-world applications. The company's funding syndicate—including Intel Capital, TPY Capital, and Korea Investment Partners—reflects global recognition of neutral-atom quantum's strategic importance and commercial potential.

Near-term validation challenges include: demonstrating qubit fidelity and coherence claims at increasingly larger array sizes, solving engineering problems in laser control and crosstalk suppression as systems scale, achieving commercializable error correction, and navigating export controls on quantum computing (especially if systems reach defense-relevant scales). Long-term success depends on sustaining technical leadership through subsequent funding rounds, recruiting and retaining world-class quantum physics talent, and converting early scientific achievements into defensible commercial product and IP. The quantum computing market is moving rapidly—larger players (Google, IBM, IonQ) are advancing through Series C/D and beyond, and government quantum initiatives (EU, China, US, Japan) are providing alternative sources of capital and customer demand. Q-Factor's window for maintaining technical differentiation and securing customer traction is narrowing; execution speed and product-market fit will be decisive.

Q-Factor also serves as a exemplar of Israel's strategic deep-tech positioning. While quantum computing is not explicitly a "defense" startup in the traditional sense, the dual-use nature is clear: the same technologies that enable commercial quantum applications (drug discovery, optimization) directly enable classified applications (cryptanalysis, signal intelligence, autonomous systems). This positioning—powerful commercial narrative coupled with credible national-security relevance—defines the modern Israeli venture model and aligns with Claw & Talon's thesis of identifying breakthrough deep-tech companies with strategic dual-use potential.